B

BVF INC/IL Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for BVF INC/IL with $2.5B in long positions as of Q3 2025, 85% allocated to Healthcare, and 59% concentrated in top 10 positions.

Portfolio Value
$2.5B
Top 10 Concentration
59%
Top Sector
Healthcare (85%)
US Exposure
83%
Market Cap Focus
Small Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 84.80%Healthcare
Healthcare
84.80%

Industry Breakdown

1 industry across all sectors

Biotechnology: 84.80%Biotechnology
Biotechnology
Healthcare
84.80%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 40.69%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 43.34%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 7.41%Nano Cap (< $50M): 0.27%N/A (ETF or Unknown): 8.28%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
40.69%
Small Cap ($300M - $2B)
43.34%
Micro Cap ($50M - $300M)
7.41%
Nano Cap (< $50M)
0.27%
N/A (ETF or Unknown)
8.28%

Portfolio Concentration

Top 10 Holdings %
58.61%
Top 20 Holdings %
83.43%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
83.24%
International
16.76%
Countries
4
Largest Int'l Market
Switzerland - 8.06%
United States of America
83.24% ($2.1B)
39 holdings
Switzerland
8.06% ($198.9M)
2 holdings
Ireland
5.12% ($126.2M)
1 holdings
Canada
3.58% ($88.4M)
4 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
19.3 quarters
Avg. Top 20
14.3 quarters
Avg. All Positions
10.8 quarters
Median Holding Period
8 quarters
Persistence Rate
71.74%
Persistent Holdings Weight
81.24%
Persistent Positions
33
Longest Held
XOMA Royalty Corporation Common Stock logo
XOMA Royalty Corporation Common StockXOMA - 35 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.25%
Avg. Position Weight
2.17%
Largest Position
Kymera Therapeutics, Inc. Common Stock logo
Kymera Therapeutics, Inc. Common StockKYMR - 12.63%
Largest Ownership Stake
MoonLake Immunotherapeutics Class A Ordinary Shares logo
MoonLake Immunotherapeutics Class A Ordinary SharesMLTX - 31.10%
Avg. Ownership Stake
8.52%
Ownership Stake >5%
29
Ownership Stake >1%
37

Historical (Since Q2 2013)

Avg. New Position
2.72%
Avg. Ownership Stake
11.90%
Largest Position
Ironwood Pharmaceuticals, Inc. - Class A logo
Ironwood Pharmaceuticals, Inc. - Class AIRWD - 44.87% (Q4 2014)
Largest Ownership Stake
MoonLake Immunotherapeutics Class A Ordinary Shares logo
MoonLake Immunotherapeutics Class A Ordinary SharesMLTX - 58.91% (Q2 2022)

Portfolio Turnover

Current Quarter

Turnover Ratio
19.7%
Value Traded
$487.09M
Positions Added
6
Positions Exited
5

Historical (Since Q2 2013)

Avg. Turnover Ratio
17.0%
Avg. Positions Added
5
Avg. Positions Exited
5
Highest Turnover
50.1%
Q1 2015
Lowest Turnover
4.5%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.